Claim EA: Professional Reading CPD hours with AMA CPD Home. Learn more in our helpful article and log your hours.

The federal AMA says a national review of fitness-to-drive medical standards provides an opportunity not only to update clinical guidance, but also to address the practical realities that doctors face in making licensing decisions.

Assessing a patient’s fitness to drive is one of the challenging responsibilities faced by GPs, who must balance patient independence, employment, social participation and quality of life with broader public safety obligations.

This becomes particularly challenging when assessments involve cognitive impairment, one of the most complex aspects of fitness-to-drive decision-making.

While conditions such as epilepsy, diabetes and visual impairment often have clearly defined clinical thresholds, fitness-to-drive decisions involving dementia, mild cognitive impairment and other neurocognitive disorders frequently require the doctor to make nuanced judgements in circumstances of considerable uncertainty.

GPs are often required to piece together information from multiple imperfect sources. Patients with cognitive impairment may have limited insight into their own driving performance, and family members may provide conflicting accounts.

Functional capacity can also vary significantly over time and between environments. Yet, clinicians are expected to make decisions that may have profound implications for the patient and the wider community.

The federal AMA submission on assessing fitness to drive

In a submission to the National Transport Commission’s current review of Assessing Fitness to Drive (AFTD) standards, the federal AMA says it is concerned that many practitioners continue to rely on cognitive assessment tools such as the General Practitioner Assessment of Cognition and Mini-Mental State Examination.

While such tools may provide useful information, they were not designed to answer the specific question of whether a person can safely operate a motor vehicle,” the federal AMA submission says.

“This contributes to variability in assessment practices and uncertainty in decision-making. The review should examine whether additional guidance, validated assessment pathways, and stronger links between cognitive screening and functional driving assessment are required.”

The AMA supports further investigation of evidence-based tools that may improve consistency, objectivity and confidence in AFTD decisions.

“Recent discussions within the AMA Council of General Practice highlighted growing interest in validated assessment tools that may assist practitioners when assessing cognitively complex patients.

“Such tools have the potential to improve consistency between practitioners, reduce reliance on subjective judgement alone, and provide additional support for difficult clinical decisions.

“Importantly, the AMA does not support replacing clinical judgement with a technological solution. Fitness-to-drive assessments require consideration of the patient’s broader medical condition, functional status, personal circumstances and risk factors. However, appropriately validated tools may provide clinicians with more objective information and improve the transparency and defensibility of decisions.”

The AMA says the review should consider how emerging assessment tools, digital supports and evidence-based screening methods can be appropriately incorporated into future approaches to AFTD. It says the focus should be on improving consistency, reducing variability, and supporting practitioners faced with increasingly complex decisions.

One of the most under-recognised consequences of AFTD decisions is the impact they can have on the therapeutic relationship between doctor and patient.

“Unlike most clinical decisions, fitness-to-drive assessments can directly affect a person’s independence, employment, financial security, social participation, and overall wellbeing. Losing the ability to drive may have profound effects – particularly for older Australians, people living in regional or rural areas, and individuals who rely on their licence for work or caring responsibilities.

“As a result, practitioners are frequently required to deliver decisions that patients strongly disagree with. Decisions to restrict or remove driving privileges can lead to conflict, complaints, deterioration in trust, and disengagement from ongoing medical care.

Recent discussions within the AMA Council of General Practice highlighted growing interest in validated assessment tools that may assist practitioners when assessing cognitively complex patients. Importantly, the AMA does not support replacing clinical judgement with a technological solution.

“The AMA is concerned that some patients may become reluctant to disclose symptoms, cognitive decline or safety concerns because they fear licensing consequences. This creates a significant tension between public safety objectives and open, effective healthcare.

“The review should acknowledge that the burden of implementing the standards does not sit solely within the technical assessment process. It also sits within the consultation room, where practitioners must navigate difficult conversations that can permanently alter longstanding therapeutic relationships.”

The AMA believes current discussions about AFTD often underestimate the responsibility placed on medical practitioners. Clinicians are expected to make high-stakes decisions affecting both public safety and individual liberty, often without access to the assessment services, referral pathways or implementation supports needed to make those decisions with confidence.

It says delays in access to occupational therapy driving assessments and on-road testing can result in prolonged uncertainty for patients, inconsistent decision-making, and unnecessary pressure on treating practitioners. In many areas, waiting times can be substantial, eligibility criteria restrictive, and private assessments prohibitively expensive.

“In rural and remote regions, this is compounded with access to on-road driving assessments being limited or non-existent.

“These barriers can delay decision-making, create uncertainty for patients and practitioners, and limit the practical application of the standards. An evidence-based standard is of limited value if patients cannot readily access the assessments required to apply it.”

The submission notes that the consequences of losing a driver’s licence are not experienced equally across Australia. In metropolitan areas, alternative transport options may be available. In rural and remote communities, licence loss can affect access to healthcare, employment, education, and community participation.

“These realities should be considered when developing implementation pathways and assessment supports.”

The AMA also notes ongoing concerns regarding medico-legal responsibility and the defensibility of clinical decisions.

“Practitioners require confidence that decisions made in good faith, in accordance with the standards, will be supported by regulators and licensing authorities.”

“The review should consider opportunities to strengthen implementation resources, improve education and training, clarify pathways for escalation and referral, and provide greater support for practitioners managing complex cases.”

The AMA says it strongly supports the continued role of the AFTD standards as the nationally agreed framework for assessing fitness to drive.

“General practitioners value the standards and use them regularly in practice because they provide a consistent, evidence-based foundation for making difficult decisions.

“The standards help practitioners explain decisions to patients and families, reduce variation in clinical practice, and support a common approach across jurisdictions.

“Importantly, the standards provide practitioners with an objective framework for decisions that would otherwise rely heavily on individual judgement. This is particularly important when practitioners are required to recommend licence restrictions, periodic review, or licence cancellation.

“The existence of nationally recognised standards helps shift these conversations away from a personal judgement by the practitioner and towards a transparent discussion based on agreed clinical guidance. The AMA believes maintaining national consistency should remain a central objective of the review.

“As the standards evolve, however, the review should place equal emphasis on implementation and usability. A technically sound standard that is difficult to apply consistently in clinical practice risks undermining both practitioner confidence and road safety outcomes.”

In closing its submission, the federal AMA recommends that the review:

  • maintains nationally consistent, evidence-based medical standards for driver licensing;
  • recognises the impact of fitness-to-drive assessments on the therapeutic relationship and patient care;
  • improves access to specialist and on-road assessment services;
  • supports development and evaluation of validated assessment tools that assist clinical decision-making;
  • strengthens education, guidance and implementation support for health practitioners; and
  • ensures proposed changes are practical, feasible, and capable of consistent application across Australia.

Start typing and press Enter to search